Isa F, Gonzalez Ortiz AM, Meyer J, Hamilton JD, et al. Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial. Lancet Infect Dis 2024 Sep 2:S1473-3099(24)00421.
PMID: 39236733